A 28-year-old man from Delhi presents with a 6-month history of recurrent episodes of severe hypoglycemia (blood glucose 35–45 mg/dL) occurring 4–6 hours after meals. He also reports hepatomegaly, short stature, and a history of gout diagnosed at age 22. Serum lactate is persistently elevated at 4.5 mmol/L (normal < 2). Liver biopsy shows excessive glycogen accumulation. Which enzyme deficiency best explains this clinical picture, and what is the primary mechanism of hypoglycemia in this condition?

Explanation

## Clinical Diagnosis: Glucose-6-Phosphatase Deficiency (GSD Type I — Von Gierke's Disease) This patient's presentation is **classic for Glycogen Storage Disease Type I (Von Gierke's disease)**, caused by deficiency of **glucose-6-phosphatase**. ## Key Diagnostic Features | Feature | Finding | Significance | |---------|---------|---------------| | **Hypoglycemia timing** | 4–6 hours post-meal (postabsorptive/fasting) | Defective glycogenolysis AND gluconeogenesis — both pathways blocked at final step | | **Elevated lactate** | 4.5 mmol/L (persistent) | Glucose-6-phosphate shunted into glycolysis → excess pyruvate → lactate | | **Early-onset gout** | Age 22 | Lactic acidosis → ↑ uric acid (competes with urate for renal excretion via URAT1) | | **Hepatomegaly + glycogen accumulation** | Liver biopsy | Glucose-6-phosphate cannot be released as free glucose; accumulates as glycogen and fat | | **Short stature** | Present | Chronic hypoglycemia impairs growth hormone axis and IGF-1 signaling | **High-Yield:** The combination of **severe fasting/postabsorptive hypoglycemia + hepatomegaly + glycogen accumulation on biopsy + elevated lactate + early gout** is the classic tetrad of **GSD Type I (Von Gierke's disease)**. ## Mechanism of Hypoglycemia Glucose-6-phosphatase catalyzes the **final common step** of both glycogenolysis and gluconeogenesis: > **Glucose-6-phosphate → Free Glucose + Inorganic Phosphate** Without this enzyme: 1. **Glycogenolysis is blocked** — glycogen is broken down to glucose-6-phosphate but cannot be released as free glucose 2. **Gluconeogenesis is blocked** — all gluconeogenic substrates (lactate, amino acids, glycerol) converge on glucose-6-phosphate, which also cannot be released 3. **Glucose-6-phosphate accumulates** → shunted into glycolysis → excess pyruvate → **lactic acidosis** 4. **Hepatic glucose output fails** → **severe hypoglycemia** ## Why Lactic Acidosis Occurs in GSD-I **Clinical Pearl:** GSD Type I causes lactic acidosis because accumulated glucose-6-phosphate is shunted through glycolysis, generating excess pyruvate that is converted to lactate by lactate dehydrogenase. This is a well-recognized feature of GSD-I and is NOT exclusive to pyruvate carboxylase deficiency. Lactic acidosis in GSD-I also worsens hyperuricemia by competing with urate for renal tubular excretion (URAT1 transporter), explaining early-onset gout. ## Why the Other Options Are Incorrect - **Option A (Fructose-1,6-bisphosphatase deficiency):** Causes hypoglycemia and lactic acidosis but does NOT cause significant glycogen accumulation in the liver, and hepatomegaly is less prominent. Gout can occur but the full triad with hepatomegaly and glycogen accumulation on biopsy is not characteristic. - **Option B (Aldolase deficiency):** Extremely rare; causes hemolytic anemia and liver disease but is not associated with this classic metabolic picture. - **Option D (Pyruvate carboxylase deficiency):** Causes lactic acidosis and hypoglycemia but does NOT cause hepatomegaly or significant glycogen accumulation. It is primarily a neurological disease in its severe form. The stem's hepatomegaly and liver biopsy findings are inconsistent with this diagnosis. ## Textbook Reference Per **Harper's Illustrated Biochemistry (31st ed.)** and **Nelson Textbook of Pediatrics**: GSD Type I (Von Gierke's disease) is defined by glucose-6-phosphatase deficiency, presenting with fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperuricemia, and hyperlipidemia. Liver biopsy shows massive glycogen and fat accumulation. **Key Point:** Glucose-6-phosphatase is the gatekeeper for hepatic glucose output — its deficiency simultaneously blocks both glycogenolysis and gluconeogenesis at the final step, making it the most severe of the glycogen storage diseases.